Dr Sudipto Pakrasi

Corneal Transplant Surgery (Keratoplasty) Corneal transplant surgery, or keratoplasty, is a specialized procedure to replace damaged or diseased corneal tissue with healthy tissue from a human donor. Modern surgical techniques allow for "component surgery," where surgeons replace only the specific damaged layers of the eye, significantly improving success rates and recovery times. When You Should Consider Corneal Transplant Surgery Keratoconus: When progressive thinning causes the cornea to bulge into a cone shape and specialty lenses no longer restore vision. Fuchs’ Dystrophy: If you experience persistent swelling or cloudiness due to the deterioration of the innermost cell layers. Corneal Scarring: To restore vision lost to physical trauma, chemical burns, or severe infections like herpes keratitis. Graft Failure: When a previous donor transplant has been rejected by the body or has stopped functioning. Advanced Thinning: When medical treatments like cross-linking can no longer provide structural integrity or relieve chronic eye pain. How Is Performed Anesthesia: Typically performed as an outpatient procedure under either local or general anesthesia, depending on the complexity. Tissue Removal: The surgeon uses high-precision tools to carefully remove the diseased or damaged layers of the patient's cornea. Methods of Transplant: Penetrating Keratoplasty (PKP): A full-thickness transplant where the entire central cornea is replaced and secured with microscopic sutures. Deep Anterior Lamellar Keratoplasty (DALK): Replaces the front and middle layers while preserving the patient's own healthy inner lining. Endothelial Keratoplasty (DMEK/DSAEK): Minimally invasive procedures to replace only the innermost layer (endothelium). Securing the Graft: In full-thickness surgeries, fine sutures are used. In endothelial transplants, a specialized Air Bubble Tamponade is used to hold the new tissue in place against the eye. Duration: The surgical procedure typically lasts between 1 to 2 hours. Pre-Procedure Preparation Comprehensive Eye Examination: To determine exactly which layers of the cornea need replacement (full-thickness vs. lamellar). Graft Matching: Sourcing high-quality donor tissue from an eye bank and reviewing success rates, which often exceed 90%. Recovery Planning: Preparing for post-operative requirements, such as strict face-up positioning for several days. Medication Review: Discussing the necessity of long-term or life-long steroid eye drops to inhibit immune rejection. Anesthesia Assessment: Evaluating overall health to determine the safest sedation method for the patient. Tests Before Corneal Transplant Surgery Pachymetry: To measure corneal thickness and identify specific areas of extreme thinning or fluid buildup (edema). Specular Microscopy: A detailed evaluation of the health and density of the endothelial cell layer. Corneal Topography: Creating a 3D map of the curvature and surface irregularities of the diseased cornea. Visual Acuity Test: Establishing a clear baseline of current vision impairment to measure post-surgical improvement. Life After Corneal Transplant Surgery Positioning Requirements: For DMEK or DSAEK, patients must maintain a face-up position for several days to allow the air bubble to support the graft. Steroid Regimen: A committed long-term schedule of steroid eye drops is required to prevent the immune system from attacking the new tissue. Rejection Monitoring: Patients must immediately report "RSVP" symptoms: Redness, Sensitivity to light, Vision blurriness, or Pain. Recovery Timeline: Healing varies by procedure—weeks for endothelial transplants (DMEK) and 6 to 12 months for full-thickness (PKP) procedures. Follow-up Care: Regular appointments are necessary to manage the sutures and monitor for potential risks like glaucoma or astigmatism. Why Specialized Treatment Is Highly Effective Restores Transparency: Effectively clears vision by replacing opaque or scarred tissue with crystal-clear donor tissue. Reduced Rejection Risk: Modern "component" surgery (DALK/DMEK) leaves more of the patient's own tissue intact, lowering the chance of an immune response. Last-Resort Solutions: For patients who cannot receive human donor tissue, an Artificial Cornea (Keratoprosthesis) offers a high-tech synthetic alternative. Eliminates Chronic Pain: Resolves the significant discomfort associated with corneal surface diseases and recurring erosions. Proven Success: Keratoplasty remains the most common and successful type of human organ transplant worldwide.

Corneal Collagen Cross-linking (CXL) Corneal Collagen Cross-linking (CXL) is a specialized medical procedure used to treat Keratoconus, a progressive condition where the cornea thins and bulges into a cone shape. Unlike LASIK or SMILE, which are designed to correct vision, the primary goal of CXL is to strengthen the corneal tissue to stop the disease from worsening and prevent future vision loss. When You Should Consider CXL Progressive Keratoconus: When repeat eye exams show that the cornea is continuing to thin or the "cone" shape is becoming more pronounced. Post-LASIK Ectasia: A rare complication where the cornea becomes unstable and thins following refractive surgery. Pellucid Marginal Degeneration: A similar corneal thinning condition that affects the lower part of the cornea. Fluctuating Vision: When your eyeglass or contact lens prescription is changing rapidly due to corneal instability. Early Diagnosis: It is highly effective when performed early to stabilize the cornea before significant vision loss occurs. How Is Performed Numbing: Anesthetic eye drops are applied so the patient remains comfortable and feels no pain during the process. Epithelium Management: Epi-off Method: The thin outer layer (epithelium) is gently removed to allow the medication to saturate the deeper layers more effectively. Epi-on (Trans-epithelial): The outer layer is left intact, which may reduce post-operative discomfort. Riboflavin Saturation: Vitamin B2 (riboflavin) drops are applied to the eye every few minutes for about 30 minutes until the cornea is fully saturated. UV Light Exposure: The eye is exposed to a controlled amount of Ultraviolet A (UVA) light for several minutes. The Chemical Reaction: The interaction between the Riboflavin and UV light creates new "cross-links" (chemical bonds) between the collagen fibers, making the cornea stiffer and more stable. Bandage Lens: A clear, soft contact lens is placed on the eye to protect the surface while it heals. Duration: The entire treatment typically takes 30 to 60 minutes. Pre-Procedure Preparation Corneal Mapping: Detailed scans (topography) are taken to document the current shape and thickness of the cornea as a baseline. Contact Lens Holiday: Patients must stop wearing hard or gas-permeable contact lenses for several weeks before the procedure to allow the cornea to settle. Medication Review: Discussing any history of slow healing or eye infections with your specialist. Transportation: Arranging for a ride home, as the eye may be sensitive to light and vision may be blurry immediately after the UV exposure. Tests Before CXL Pachymetry: To measure the thinnest point of the cornea; a minimum thickness is often required to safely perform the UV light stage. Corneal Topography/Tomography: To identify the "apex" of the cone and track the rate of disease progression. Slit-Lamp Examination: To check for any pre-existing corneal scarring that might affect the treatment outcome. Visual Acuity: Establishing the current level of corrected and uncorrected vision. Life After CXL Initial Discomfort: Especially in "Epi-off" cases, the eye may feel sore, gritty, or highly light-sensitive for the first 3–5 days. Vision Fluctuations: It is normal for vision to be slightly "foggy" or worse immediately after the procedure before it stabilizes over several weeks. Medication Regimen: Patients must use prescribed antibiotic and steroid drops for several weeks to prevent infection and manage inflammation. Healing Timeline: While the surface heals within a week, the full strengthening effect of the cross-linking takes 3 to 6 months to reach maximum stability. Follow-up Care: Regular checkups are essential to monitor the "haze" (temporary cloudiness) and ensure the epithelium has regrown properly. Why Specialized Treatment Is Highly Effective Prevents Disease Progression: CXL has a success rate of over 90% in stopping Keratoconus from getting worse. Avoids Major Surgery: By stabilizing the cornea early, the vast majority of patients can avoid the need for a full corneal transplant later in life. Long-Term Stability: The new chemical bonds created between collagen fibers provide a permanent increase in corneal rigidity. Preserves Vision: While it does not eliminate the need for glasses, it "locks" the vision in place and prevents further deterioration. Minimally Invasive: It is an outpatient procedure that does not require stitches or a long hospital stay.

Corneal Collagen Cross-linking (CXL) Corneal Collagen Cross-linking (CXL) is a specialized medical treatment designed to stop the progression of Keratoconus and other corneal thinning disorders. Unlike most laser eye surgeries, its goal is not to improve vision, but to strengthen and stabilize the cornea's structure. By creating new chemical bonds between corneal fibers, CXL acts as a support system to prevent the eye from bulging further. When You Should Consider CXL Progressive Keratoconus: When regular eye exams show that the cornea is continuing to thin or the "cone" shape is becoming more pronounced. Post-LASIK Ectasia: A rare condition where the cornea becomes unstable and begins to thin following previous refractive surgery. Pellucid Marginal Degeneration: A specific type of corneal thinning that typically affects the lower portion of the cornea. Rapidly Changing Vision: When your eyeglass or contact lens prescription is shifting frequently due to structural changes in the eye. Early Diagnosis: It is most effective when performed early to "lock" the cornea in place before significant vision loss occurs. How Is Performed Numbing: Anesthetic eye drops are applied so the patient remains comfortable and feels no pain throughout the process. Epithelium Management: Epi-off Method: The thin outer layer (epithelium) is gently removed to allow the riboflavin medicine to penetrate the deeper layers more effectively. Epi-on (Trans-epithelial): The outer layer is left intact, which may lead to less post-operative discomfort but sometimes slower saturation. Riboflavin Loading: Vitamin B2 (riboflavin) drops are applied every few minutes for about 30 minutes until the cornea is fully saturated. UVA Activation: The eye is exposed to a precise, controlled beam of Ultraviolet-A light. The Cross-linking: The UV light reacts with the riboflavin to create new "cross-links" (chemical bonds) between the collagen fibers, making the cornea stiffer. Protection: A clear, soft bandage contact lens is placed on the eye to protect the surface while the epithelium regrows. Duration: The entire treatment typically takes between 30 and 60 minutes. Pre-Procedure Preparation Baseline Mapping: Detailed 3D scans (topography) are taken to document the current shape and thickness of the cornea. Contact Lens Holiday: Patients must stop wearing hard or gas-permeable contact lenses for several weeks before the procedure to ensure the cornea is in its natural state. Medication Audit: Reviewing any history of slow healing, dry eyes, or chronic eye infections with the surgical team. Transportation Planning: Arranging for a ride home, as the eye will be sensitive to light and vision may be blurry immediately following the UV exposure. Tests Before CXL Pachymetry: To measure the thickness of the cornea at its thinnest point; a safe minimum thickness is required for the UV light phase. Corneal Topography/Tomography: To identify the "apex" of the cone and track the exact rate of disease progression over time. Slit-Lamp Examination: A microscopic check for any pre-existing corneal scarring or inflammation that might impact the outcome. Visual Acuity Test: Establishing the current level of corrected vision to monitor stability after the procedure. Life After CXL Initial Discomfort: Especially in "Epi-off" cases, the eye may feel sore, gritty, or highly light-sensitive for the first 3–5 days. Vision Fluctuations: It is normal for vision to be "hazy" or slightly worse than before surgery for a few weeks while the surface heals. Medication Regimen: Patients must strictly follow the schedule for prescribed antibiotic and steroid drops for several weeks. Stabilization Timeline: While the surface heals within a week, the full strengthening effect and final vision stabilization can take 3 to 6 months. Follow-up Care: Regular checkups are essential to monitor "corneal haze" (temporary cloudiness) and confirm the epithelium has fully regrown. Why Specialized Treatment Is Highly Effective Stops Disease Progression: CXL is highly successful at preventing the cornea from bulging further and worsening the condition. Prevents Major Surgery: By stabilizing the cornea early, most patients can avoid the need for a full corneal transplant later in life. Permanent Strengthening: The new chemical bonds provide a long-term increase in corneal rigidity and structural integrity. Preserves Vision Quality: While it may not eliminate the need for glasses, it "locks" the vision in place and prevents further loss of sight. Minimally Invasive: It is an outpatient procedure that requires no incisions into the inner eye and no stitches.

Phacoemulsification (Cataract Surgery) Phacoemulsification, commonly referred to as "phaco," is the modern gold standard for cataract surgery. This procedure uses ultrasonic energy to fragment a clouded natural lens (cataract), allowing it to be removed through a microscopic, often stitchless incision. It is then replaced with a permanent artificial intraocular lens (IOL) to restore clear vision. When You Should Consider Phacoemulsification Cloudy or Blurry Vision: When daily activities like reading or driving become difficult due to a "foggy" lens. Glare and Halos: Increased sensitivity to light, especially during night driving. Fading Colors: When vibrant colors appear yellowed, dull, or faded. Frequent Prescription Changes: Rapid changes in eyeglass or contact lens strength. Double Vision: Experiencing multiple images in a single eye. How Is Performed Anesthesia: Numbing eye drops (topical anesthesia) or a local injection are used so the patient remains awake but feels no pain. The Incision: A microscopic, self-sealing incision (typically 2.2 to 2.8 mm) is made at the edge of the cornea. Capsulorhexis: A precise circular opening is created in the thin membrane (capsule) that surrounds the lens. Phacoemulsification: A specialized probe emitting ultrasonic waves vibrates at high frequencies to fragment the cataract into tiny pieces. Aspiration: The fragmented pieces are gently suctioned out of the eye using the same high-tech probe. IOL Implantation: A foldable artificial lens is inserted through the tiny incision; it unfolds naturally inside the lens capsule to restore focus. Closure: Because of the precise shape of the incision, stitches are usually unnecessary. Pre-Procedure Preparation Eye Measurement (Biometry): Precise ultrasound or laser measurements are taken to determine the correct power of the artificial lens (IOL). Medication Audit: Patients may be asked to start antibiotic or anti-inflammatory drops a few days before the procedure. Fasting: Following specific instructions regarding food and drink intake on the morning of the surgery. Transportation: Arranging for a family member or friend to drive you home, as vision will be blurry immediately after the procedure. Tests Before Cataract Surgery Visual Acuity Test: To measure exactly how much the cataract is affecting your sight. Slit-Lamp Examination: A detailed microscopic look at the front structures of the eye, including the lens. Retinal Exam: Checking the back of the eye to ensure the retina is healthy and capable of good vision after surgery. Keratometry: Measuring the curvature of the cornea to help select the most appropriate artificial lens. Life After Phacoemulsification Initial Vision: Vision may be blurry for the first 24–48 hours but typically improves rapidly as the eye heals. Medication: Patients must use prescribed antibiotic and anti-inflammatory eye drops for several weeks to prevent infection. Eye Protection: A plastic shield is often worn while sleeping for the first week to prevent accidental rubbing or pressure. Activity Restrictions: Avoid heavy lifting, bending over, or getting water/soap in the eye for at least the first 2–3 weeks. Follow-up: Regular checkups ensure the IOL is perfectly positioned and the eye pressure remains stable. Why Specialized Treatment Is Highly Effective Rapid Recovery: Most patients return to light daily activities within one to two days. Micro-Incision Precision: Smaller incisions significantly reduce the risk of surgically induced astigmatism. Customized Vision: Modern IOLs can correct pre-existing nearsightedness, farsightedness, or even presbyopia (reading vision). Minimal Complications: Advanced technology has lowered the risks of infection, bleeding, and inflammation compared to older methods. Permanent Solution: Once the clouded lens is removed and replaced, a cataract cannot grow back on the artificial lens.

Trabeculectomy (Glaucoma Surgery) Trabeculectomy is a specialized surgical procedure used to treat glaucoma by creating a new drainage pathway to lower the internal pressure of the eye (IOP). It is typically recommended when eye drops or laser treatments are no longer effective at preventing progressive optic nerve damage and vision loss. When You Should Consider Trabeculectomy Uncontrolled Glaucoma: When your intraocular pressure remains high despite the maximum use of eye drops or oral medications. Progressive Vision Loss: If visual field tests show that your peripheral vision is continuing to deteriorate. Optic Nerve Damage: When clinical examinations show worsening "cupping" or thinning of the optic nerve fibers. Inadequate Laser Results: If previous procedures like Selective Laser Trabeculoplasty (SLT) have failed to maintain a safe pressure level. Advanced Disease: In cases of severe glaucoma where a very low "target pressure" is required to preserve the remaining sight. How Is Performed Anesthesia: The surgery is usually performed as an outpatient procedure under local anesthesia and takes about 45 to 60 minutes. Creating the Flap: The surgeon creates a microscopic "trapdoor" (flap) in the sclera—the white part of the eye—usually hidden under the upper eyelid. Removing Tissue: A tiny piece of the eye's blocked drainage meshwork is removed from under the flap to create a new opening. The "Bleb": The flap is loosely stitched back in place, allowing fluid (aqueous humor) to bypass the blocked natural drains and flow into a small reservoir called a Filtering Bleb. Fluid Absorption: The fluid in the bleb is naturally reabsorbed by the surrounding blood vessels, effectively lowering the pressure inside the eye. Anti-Scarring Medication: Medications like Mitomycin-C (MMC) are applied during surgery to prevent the new drainage hole from scarring shut. Pre-Procedure Preparation Pressure Mapping: Recording several pressure readings to establish the baseline and determine the "target pressure" needed for safety. Medication Audit: Reviewing current glaucoma drops; some may need to be stopped or adjusted before surgery to reduce inflammation. Infection Screen: Ensuring the eyelids and tear ducts are healthy and free of infection before the procedure. Transportation: Arranging for a ride home, as the eye will be patched and vision will be temporarily blurry. Anesthesia Discussion: Confirming the type of sedation or local numbing that will be used for your comfort. Tests Before Trabeculectomy Visual Field Test: To document the current extent of peripheral vision loss and provide a baseline for post-operative monitoring. Optical Coherence Tomography (OCT): To measure the thickness of the retinal nerve fiber layer around the optic nerve. Gonioscopy: A specialized exam using a mirrored lens to view the drainage angle and plan the surgical entry point. Pachymetry: Measuring corneal thickness, which can influence how eye pressure readings are interpreted. Life After Trabeculectomy Initial Vision: Vision is usually blurry for the first 2 to 4 weeks as the eye pressure stabilizes and the internal fluid levels adjust. Frequent Check-ups: Close monitoring is required in the first few weeks to allow the surgeon to adjust stitches or manage the flow of fluid. Medication Regimen: Patients must strictly use prescribed antibiotic and steroid eye drops for several weeks to prevent infection and control inflammation. Activity Restrictions: Avoid heavy lifting, bending over, or strenuous exercise for about one month to prevent dangerous pressure spikes. Long-Term Monitoring: Because there is a permanent "hole" in the eye, patients must watch for signs of Blebitis (infection of the bleb), such as sudden redness or pain. Why Specialized Treatment Is Highly Effective Significant Pressure Reduction: It is one of the most powerful tools available for achieving the very low pressures needed in advanced glaucoma. Protects Remaining Sight: By reaching the target pressure, the procedure stops the ongoing "mechanical" damage to the optic nerve. Outpatient Experience: Allows for major internal eye reconstruction with minimal downtime and a return to home on the same day. Customizable Flow: The use of adjustable or "removable" sutures allows the surgeon to fine-tune the eye pressure in the office after the surgery. Long-Lasting Results: When the bleb heals correctly and remains functional, it can provide years of stable pressure control without the need for additional drops.

Glaucoma Drainage Device (GDD) Implant A Glaucoma Drainage Device (GDD) implant, also known as a tube shunt or aqueous shunt, is a specialized medical device used to lower intraocular pressure (IOP). This procedure is typically reserved for cases where conventional treatments, such as eye drops, laser therapy, or trabeculectomy, have been insufficient or are likely to fail. When You Should Consider a GDD Implant Refractory Glaucoma: When previous glaucoma surgeries, like a trabeculectomy, have failed or are high-risk due to scarring. Neovascular Glaucoma: If abnormal blood vessel growth in the eye is blocking the natural drainage angles. Uveitic Glaucoma: For managing high pressure caused by chronic internal eye inflammation. Traumatic Glaucoma: When physical injury to the eye has permanently damaged the natural drainage meshwork. Congenital Glaucoma: In pediatric cases where the eye's drainage system did not develop correctly. How Is Performed Anesthesia: The procedure is usually performed as an outpatient surgery under local anesthesia with sedation and takes about one hour. Incision: A small pocket is created under the conjunctiva (the clear membrane covering the white of the eye). Plate Fixation: A thin, curved silicone plate is sutured to the sclera (the white part of the eye), usually tucked high under the upper eyelid. Tube Insertion: A microscopic, flexible tube is trimmed and inserted into the front chamber of the eye to create a new drainage channel. Patch Graft: A small piece of donor tissue (sclera or cornea) is often placed over the tube to protect it and prevent it from eroding through the eye's surface. Fluid Flow: Excess fluid (aqueous humor) flows through the tube to the plate, where it forms a reservoir (bleb) and is naturally absorbed by the body. Common Implant Models Valved Implants (e.g., Ahmed Valve): These feature a pressure-sensitive valve that limits fluid flow until a specific pressure is reached, helping to prevent the eye pressure from dropping too low (hypotony) immediately after surgery. Non-Valved Implants (e.g., Baerveldt or Molteno): These lack a valve and offer a larger surface area for drainage. The surgeon often temporarily ties off the tube during surgery to allow a protective capsule to form before drainage begins. Pre-Procedure Preparation Surgical Planning: A detailed evaluation to choose between a valved or non-valved device based on your specific pressure goals. Medication Review: Discussing current glaucoma drops; some may need to be adjusted to manage inflammation before the implant. Donor Tissue Coordination: Ensuring the necessary patch graft material is available for the day of surgery. Transportation: Arranging for a companion to drive you home, as the eye will be patched and vision will be temporarily blurry. Physical Readiness: Confirming you are comfortable lying still for approximately one hour during the micro-surgical steps. Tests Before GDD Surgery Gonioscopy: A specialized exam to view the internal drainage angle and determine the safest placement for the tube. Visual Field Test: Establishing a baseline of peripheral vision to monitor the long-term success of the pressure control. Endothelial Cell Count: Checking the health of the inner cornea, as the tube's position must not interfere with these delicate cells. Intraocular Pressure (IOP) Profile: Tracking your pressure fluctuations to confirm the need for a surgical shunt. Life After a GDD Implant Initial Vision: Vision may be blurry for several days to a few weeks as the eye adjusts to the new drainage system. Activity Restrictions: Patients must avoid bending over, straining, or lifting objects heavier than 5 kg for several weeks to prevent pressure spikes or tube movement. Medication Use: Most patients will still need to continue some glaucoma medications even after the implant is fully functional. Monitoring: Regular checkups are essential to ensure the tube is in the correct position and the plate is draining fluid effectively. Safety Watch: Monitor for rare signs of complications, such as double vision (if the plate affects eye muscles) or redness at the patch graft site. Why Specialized Treatment Is Highly Effective Robust Pressure Control: Offers a reliable long-term solution for eyes that do not respond to other forms of glaucoma treatment. Bypasses Scarred Tissue: Because the tube is inserted directly into the eye, it bypasses damaged or scarred natural drainage channels. Standard of Care for Complex Cases: Successfully manages pressure in high-risk conditions like neovascular or inflammatory glaucoma. Durable Design: The silicone materials used are highly biocompatible and designed to remain functional inside the eye for many years. Predictable Outcomes: Modern surgical techniques and a variety of implant sizes allow surgeons to tailor the treatment to the specific volume of the patient's eye.

Laser Iridotomy (LPI) Laser Iridotomy, or Laser Peripheral Iridotomy (LPI), is a quick outpatient procedure used primarily to treat or prevent angle-closure glaucoma. By creating a microscopic hole in the outer edge of the iris, the procedure allows fluid to flow more freely between the back and front of the eye. This bypass balances internal pressure and prevents sudden, sight-threatening pressure spikes. When You Should Consider Laser Iridotomy Narrow-Angle Suspects: If a routine eye exam reveals that your drainage angles are naturally narrow, putting you at high risk for a sudden glaucoma "attack." Acute Angle-Closure: Used as an emergency intervention during a sudden, painful spike in eye pressure to save vision. Chronic Angle-Closure: For patients whose drainage system is permanently narrowed or partially blocked by the iris. Preventative Care: If you have had an angle-closure attack in one eye, LPI is typically performed on the other eye as a preventative measure. Anatomical Narrowing: When the iris is physically "bowed" forward, preventing the natural drainage of aqueous humor. How Is Performed Preparation: The eye is numbed with anesthetic drops. Specialized drops (like pilocarpine) are used to constrict the pupil, which thins the iris and makes it easier for the laser to penetrate. Positioning: You sit at a slit-lamp machine—similar to a standard eye exam microscope—with your chin and forehead in a steady rest. Focusing: A specialized contact lens is placed on the eye to focus the laser beam and keep your eyelids open during the pulses. Laser Application: The surgeon uses a focused laser (commonly a YAG or Argon laser) to create a tiny opening in the outer edge of the iris, usually hidden under the upper eyelid. Monitoring: You will remain at the clinic for 30 minutes to 2 hours post-procedure so the specialist can check for any immediate spikes in eye pressure. Duration: The procedure is typically completed in 5 to 15 minutes per eye. Pre-Procedure Preparation Gonioscopy: A specialized diagnostic exam to view the drainage angle and confirm that the iris is causing the obstruction. Medication Review: Discussing any blood thinners or history of eye inflammation (uveitis) with your surgeon. Pupil Preparation: Being aware that the constricting drops used before surgery may cause a temporary brow ache or dim vision. Transportation: Arranging for a ride home, as your vision may be temporarily blurred from the specialized lenses and laser light. Tests Before Laser Iridotomy Intraocular Pressure (IOP) Check: Establishing a baseline pressure to compare against post-laser readings. Anterior Segment OCT: A high-resolution scan that provides a cross-sectional view of the drainage angle and iris position. Visual Acuity: Measuring your current vision to ensure the laser treatment does not affect your baseline sight. Slit-Lamp Examination: A microscopic check of the iris thickness and the health of the cornea before the laser application. Life After Laser Iridotomy Initial Recovery: Most patients return to normal activities within 24 to 48 hours. Common Symptoms: Temporary blurred vision, mild headache, light sensitivity, or a "gritty" feeling in the eye are normal for a day or two. Medication: You will be prescribed anti-inflammatory (steroid) eye drops to use for about a week to ensure the microscopic hole stays open and heals. Activity Restrictions: Avoid strenuous exercise, heavy lifting, or rubbing the eyes for the first 2–3 days. Follow-up: A pressure check and gonioscopy are usually performed 1 to 2 weeks later to confirm the angle has successfully opened. Why Specialized Treatment Is Highly Effective Prevents Blindness: It is the primary defense against acute angle-closure glaucoma, which can cause permanent blindness in hours if untreated. Minimally Invasive: Requires no surgical incisions, no stitches, and is performed entirely in an office setting. Permanent Solution: Once the microscopic hole is created and healed, it typically provides a life-long pathway for fluid flow. Rapid Results: The internal pressure often begins to stabilize immediately after the bypass is created. High Safety Profile: Complications are uncommon, and the procedure is considered the global standard of care for narrow-angle conditions.

MIGS (Minimally Invasive Glaucoma Surgery) Minimally Invasive Glaucoma Surgery (MIGS) is a group of modern surgical techniques designed to lower eye pressure with significantly less trauma than traditional glaucoma surgeries. These procedures use microscopic incisions and specialized devices to improve fluid drainage, typically for patients with mild-to-moderate open-angle glaucoma who wish to reduce their dependence on daily eye drops. When You Should Consider MIGS Mild-to-Moderate Glaucoma: When your eye pressure is not adequately controlled by one or two types of eye drops. Concurrent Cataract Surgery: MIGS is frequently performed alongside cataract removal, as it uses the same tiny incision and adds only minutes to the total procedure time. Intolerance to Medications: If you experience severe dry eye, redness, or allergies caused by long-term use of glaucoma eye drops. Desire for Faster Recovery: When you require a pressure-lowering procedure but cannot afford the long downtime associated with traditional surgery. Preserving Future Options: Because MIGS is "micro-invasive," it preserves the outer layers of the eye (conjunctiva) in case more intensive surgery is needed later in life. How Is Performed Micro-Incision: The surgeon enters the eye through a microscopic incision (often only 1–2 mm) in the clear cornea. Ab Interno Approach: The procedure is performed from the inside of the eye, allowing the surgeon to view the internal drainage angle directly through a specialized lens. Methods of Treatment: Trabecular Bypass (Stents): Tiny implants like the iStent or Hydrus Microstent are placed into the eye's natural drainage canal to bypass blockages. Tissue Excision: Tools like the Kahook Dual Blade (KDB) are used to remove a small strip of the blocked meshwork to let fluid flow freely. Subconjunctival Filtration: A flexible gelatin tube, such as the Xen Gel Stent, creates a tiny tunnel to redirect fluid to a reservoir under the eye's outer membrane. Ciliary Body Ablation: A laser probe (ECP) is used inside the eye to treat the tissue that produces fluid, reducing the overall "inflow" of pressure. Duration: When performed alone, MIGS typically takes 10 to 15 minutes; when combined with cataract surgery, it adds approximately 5 to 10 minutes. Pre-Procedure Preparation Gonioscopy: A detailed exam using a mirrored lens to view your internal drainage angle and ensure it is "open" enough for MIGS. Visual Field Mapping: Documenting your current peripheral vision to establish a baseline for long-term stability. Medication Audit: Reviewing your current eye drops; your surgeon will determine if you should continue or stop them immediately after the procedure. Transportation: Arranging for a ride home, as your vision may be temporarily blurry from the surgical microscope and dilating drops. Tests Before MIGS Optical Coherence Tomography (OCT): To measure the thickness of the optic nerve fibers and assess the severity of glaucoma. Intraocular Pressure (IOP) Tracking: Recording your pressure at different times of the day to determine your "target pressure." Pachymetry: Measuring the thickness of your cornea to ensure the most accurate eye pressure readings. Endothelial Cell Count: Checking the health of the inner cornea, especially if a permanent stent is being considered. Life After MIGS Rapid Recovery: Most patients return to normal daily activities within 3 to 7 days, which is much faster than traditional glaucoma surgery. Medication Regimen: You will need to use antibiotic and anti-inflammatory eye drops for several weeks to ensure proper healing. Pressure Monitoring: Temporary "pressure spikes" can occur in the first few days, requiring close follow-up with your surgeon. Activity Restrictions: Avoid heavy lifting, swimming, or rubbing the treated eye for at least 2 to 4 weeks. Reduced Drop Burden: Many patients are able to significantly reduce or even stop their daily glaucoma eye drops once the drainage device is fully functional. Why Specialized Treatment Is Highly Effective High Safety Profile: Carries a much lower risk of serious complications like hypotony (dangerously low pressure) or severe bleeding. Versatile Pathways: Surgeons can target multiple drainage pathways (trabecular, uveoscleral, or subconjunctival) depending on your eye's unique anatomy. Standardized Precision: The use of microscopic stents and blades ensures a predictable result with minimal damage to healthy tissue. Sustained Control: Unlike eye drops, which can be forgotten or difficult to administer, a MIGS implant provides 24/7 pressure management. Synergy with Cataract Care: Offers a "two-for-one" opportunity to improve vision clarity and lower eye pressure in a single, efficient session.